ZURA

0.93052.30%
SJ

Steven J. Schoch

Independent Director

Mr. Steven J. Schoch, also known as Steve, is Chief Financial Officer of RefleXion Medical, Inc. from February 2025. Mr. Schoch was Chief Financial Officer at FLYR, Inc. He had been Director at Arena Pharmaceuticals, Inc. since June 2021 until March 11, 2022. He served as Chief Operating Officer at FLYR, Inc. Mr. Schoch served as Chief Financial and Accounting Officer of 23andMe Holding Co. until September 01, 2022. Mr. Schoch served as Chief Financial Officer and Treasurer of 23andMe, Inc. He serves as an Independent Director at Zura Bio Limited since March 21, 2023. He was the Chief Executive Officer of Miramax, LLC from 2012 to 2017 and served as its Chief Financial Officer beginning in 2010 and Executive Vice President. Mr. Schoch served as Vice President Research and Development Operations at Amgen Inc. since June 2005. He served as Vice President of Finance at Amgen Inc. since June 2001. He joined 23andMe in 2018. Mr. Schoch served as Controller of Amgen Inc. from June 2001 to June 2005. Before joining Amgen, Mr. Schoch served as Executive Vice President and Chief Financial Officer of eToys, Inc. from 1999 to 2001 and served as its Secretary. Prior to eToys, Mr. Schoch served as Vice President and Corporate Treasurer of Times Mirror Corporation from December 1995 to January 1999. He also served as Chief Executive Officer and President of a wholly owned subsidiary of Times Mirror Company dedicated to the reduction and containment of costs of the parent company. From March 1991 to October 1995, Mr. Schoch served as Vice President and Treasurer of Euro Disney S.C.A. of The Walt Disney Company. Mr. Schoch received a Bachelor of Science in Civil Engineering from Tufts University and a Masters in Business Administration from the Amos Tuck School of Business Administration at Dartmouth College.

Positions